Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
PubMatic A | PUBM | Nov 25, 2024 | 15.87 | -1.92 |
Pulmatrix | PULM | Nov 25, 2024 | 6.04 | -1.31 |
Pulmonx | LUNG | Nov 25, 2024 | 6.61 | -2.65 |
Pulse Biosciences | PLSE | Nov 25, 2024 | 17.98 | +1.73 |
PulteGroup | PHM | Nov 25, 2024 | 137.65 | +6.08 |
Puma Biotechnology | PBYI | Nov 25, 2024 | 3.02 | +0.67 |
Pure Cycle | PCYO | Nov 25, 2024 | 14.30 | +1.92 |
Pure Storage A | PSTG | Nov 25, 2024 | 53.74 | +4.03 |
PureCycle Technologies | PCT | Nov 25, 2024 | 12.92 | +8.30 |
PureCycle Technologies Unit | PCTTU | Nov 25, 2024 | 14.00 | 0.00 |
Purefunds ISE Junior Silver [Sm | SILJ | Nov 25, 2024 | 11.69 | -3.15 |
PureTech Health ADR | PRTC | Nov 25, 2024 | 22.07 | -2.13 |
Purple Biotech ADR | PPBT | Nov 25, 2024 | 2.74 | +25.11 |
Purple Innovation | PRPL | Nov 25, 2024 | 0.95 | +7.69 |
Putnam Managed Municipal Income Trust | PMM | Nov 25, 2024 | 6.21 | +0.81 |
Putnam Master Intermediate Income Trust | PIM | Nov 25, 2024 | 3.25 | +0.78 |
Putnam Municipal Opportunities Trust | PMO | Nov 25, 2024 | 10.44 | +0.77 |
Putnam Premier Income Trust | PPT | Nov 25, 2024 | 3.54 | +0.85 |
PVH | PVH | Nov 25, 2024 | 107.70 | +3.69 |
Pyrophyte Acquisition | PHYT | Nov 25, 2024 | 11.55 | 0.00 |
Pyxis Oncology | PYXS | Nov 25, 2024 | 1.89 | -0.53 |
Pyxis Tankers | PXS | Nov 25, 2024 | 3.98 | -2.45 |
Pyxis Tankers Pref | PXSAP | Nov 25, 2024 | 24.97 | 0.00 |
Q2 | QTWO | Nov 25, 2024 | 107.36 | +0.93 |
Q32 Bio | QTTB | Nov 25, 2024 | 25.44 | +3.63 |
QCR | QCRH | Nov 25, 2024 | 93.24 | +0.62 |
QIAGEN | QGEN | Nov 25, 2024 | 43.25 | +1.10 |
Qifu Technology ADR | QFIN | Nov 25, 2024 | 33.85 | -1.97 |
QMMM | QMMM | Nov 25, 2024 | 1.09 | +45.35 |
Qomolangma Acquisition | QOMO | Nov 25, 2024 | 11.55 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.